Burden of illness for an employed population with chronic obstructive pulmonary disease

Population Health Management

Volumn 15, Issue 5, 2012, Pages 267-275

  Nair, Kavita ^a   Ghushchyan, Vahram ^a   Van Den Bos, Jill ^b   Halford, Michael L ^b   Tan, Gideon ^b   Frech Tamas, Feride H ^c   Doyle, Joseph ^c  

^a UNIVERSITY OF COLORADO   (United States)

^b MILLIMAN INC   (United States)

^c NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BINOMIAL DISTRIBUTION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; EMERGENCY WARD; EMPLOYMENT; FEMALE; HEALTH CARE COST; HEALTH PROGRAM; HOSPITALIZATION; HUMAN; INSURANCE; MAJOR CLINICAL STUDY; MALE; PROPENSITY SCORE; TREATMENT OUTCOME; UNITED STATES;

ADOLESCENT; ADULT; AGED; DISEASE MANAGEMENT; FEMALE; HEALTH CARE COSTS; HEALTH EXPENDITURES; HEALTH STATUS INDICATORS; HUMANS; INSURANCE CLAIM REVIEW; LOGISTIC MODELS; MALE; MIDDLE AGED; OCCUPATIONAL HEALTH; PROPENSITY SCORE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; UNITED STATES; YOUNG ADULT;

EID: 84866340894     PISSN: 19427891     EISSN: 19427905     Source Type: Journal    
DOI: 10.1089/pop.2011.0049     Document Type: Article

References (38)

1. American Lung Association. Chronic obstructive pulmonary disease (COPD) fact sheet. Available at: http://www .lungusa.org/lung-disease/copd/resources/ facts-figures/ COPD-Fact-Sheet.html#note-01. Accessed February 14, 2011.
2. Mannino DM, Homa DM, Akinbami LJ, Ford ES, Redd SC. Chronic obstructive pulmonary disease surveillance-United States, 1971-2000. MMWR. 2002;51:1-16.
3. National Heart Lung and Blood Institute. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: NHLBI/WHO workshop. 2004. Available at: http://www.goldcopd.org/Guidelines/ guidelines-global-strategy-for-diagnosis-management-2004- 2.html. Acessed September 29, 2011.
4. American Lung Association. Trends in COPD (chronic bronchitis and emphysema): morbidity and mortality. Available at: http://www.lungusa.org/ finding-cures/ourresearch/ trend-reports/copd-trend-report.pdf. Accessed March 28, 2011.
5. US Census Bureau. Projected population of the United States by age and sex: 2000 to 2050. Available at: http://www .census.gov/population/www/ projections/usinterimproj/ natprojtab02a.pdf. Accessed September 29, 2011.
6. American Association for Respiratory Care. Confronting COPD in America: Executive Summary. Available at: http:// www.aarc.org/resources/confronting- copd/exesum.pdf. Accessed March 28, 2011.
7. Kochanek KD, Xu JQ, Murphy SL, Minino AM, Kung HC. Deaths: Preliminary Data for 2009. National Vital Statistics Reports; Vol 59, No 4 Hyattsville, MD: National Center for Health Statistics; 2011.
8. National Heart Lung and Blood Institute. Morbidity and Mortality: 2009 Chart Book on Cardiovascular, Lung, and Blood Diseases. Available at: http://www.nhlbi.nih.gov/ resources/docs/cht-book.htm. Accessed October 3, 2011.
9. Goetzel RZ, Hawkins K, Ozminkowski RJ, Wang S. The health and productivity cost burden of the "top 10" physical and mental health conditions affecting six large US employers in 1999. J Occup Environ Med. 2003;45:5-14.
10. Foster TS, Miller JD, Marton JP, Caloyeras JP, Russell MW, Menzin J. Assessment of the economic burden of COPD in the US: A review and synthesis of the literature. COPD. 2006;3:211-218.
11. Kronick R, Gilmer T, Dreyfus T, Lee L. Improving healthbased payment for Medicaid beneficiaries: CDPS. Health Care Financ Rev. 2000;21:29-64.
12. Gilmer T, Kronick R, Fishman P, Ganiats TG. The Medicaid Rx model: Pharmacy-based risk adjustment for public programs. Med Care. 2001;39:1188-1202.
13. Winkelman RA, Mehmud SM. A comparative analysis of claims-based tools for health risk assessment. Available at: http://www.soa.org/files/pdf/risk- assessmentc.pdf. Accessed September 26, 2011.
14. Weir S, Aweh G, Clark RE. Case selection for a Medicaid chronic care management program. Health Care Financ Rev. 2008;30:61-74.
15. Rubin DB. Estimating causal effects from large data sets using propensity scores. Ann Intern Med. 1997;127:757-763.
16. Rubin DB, Thomas N. Matching using estimated propensity scores: Rrelating theory to practice. Biometrics. 1996;1:249- 264.
17. Cameron AC, Trivedi PK. Regression Analysis of Count Data. Cambridge UK: University Press; 1998.
18. Berk R, MacDonald J. Overdispersion and Poisson regression. J Quant Criminol. 2008;24:269.
19. Sullivan PW, Ghushchyan V, Wyatt HR, Hill JO. The medical cost of cardiometabolic risk factor clusters in the United States. Obesity. 2007;15:3150-3158.
20. Heckman JJ. Sample selection bias as a specification error. Econometrica. 1979;47:153-161.
21. Sullivan PW, Ghushchyan V, Ben-Joseph RH. The effect of obesity and cardiometabolic risk factors on expenditures and productivity in the United States. Obesity. 2008;16:2155- 2162.
22. Peytremann-Bridevaux I, Staeger P, Bridevaux PO, Ghali WA, Burnand B. Effectiveness of chronic obstructive pulmonary disease-management programs: A systematic review and meta-analysis. Am J Med. 2008;121:433-443.
23. Lemmens KM, Nieboer AP, Huijsman R. A systematic review of integrated use of disease-management interventions in asthma and COPD. Respir Med. 2009;103:670-691.
24. Dewan NA, Rice KL, Caldwell M, Hilleman DE. Economic evaluation of a disease management program for chronic obstructive pulmonary disease. COPD. 2011;8:153-159.
25. Tinkelman D, Bunn WB, Vogenberrg FR. Workplace wellness and disease prevention: Focus on COPD. Am Health Drug Benefits. 2009;2:194-200.
26. Darkow T, Kadlubek PJ, Shah H, Phillips AL, Marton JP. A retrospective analysis of disability and its related costs among employees with chronic obstructive pulmonary disease. J Occup Environ Med. 2007;49:22-30.
27. Halpern MT, Stanford RH, Borker R. The burden of COPD in the USA: Results from the Confronting COPD Survey. Respir Med. 2003;97:S81-S89.
28. Sin DD, Stafinski T, Ng YC, Bell NR, Jacobs P. The impact of chronic obstructive pulmonary disease on work loss in the United States. Am J Respir Crit Care Med. 2002;165:704-707.
29. Menzin J, Boulanger L, Marton J, et al. The economic burden of chronic obstructive pulmonary disease (COPD) in a US Medicare population. Respir Med. 2008;102:1248-1256.
30. Nurmagambetov T, Atherly A, Williams S, Holguin F, Mannino DM, Redd SC. What is the cost to employers of direct medical care for chronic obstructive pulmonary disease? COPD. 2006;3:203-209.
31. Marton JP, Boulanger L, Friedman M, Dixon D, Wilson J, Menzin J. Assessing the costs of chronic obstructive pulmonary disease: The state Medicaid perspective. Respir Med. 2006;100:996-1005.
32. Tinkelman DG, George D, Halbert RJ. Chronic obstructive pulmonary disease in patients under age 65: utilization and costs from a managed care sample. J Occup Environ Med. 2005;47:1125-1130.
33. Miller JD, Foster T, Boulanger L, et al. Direct costs of COPD in the US: An analysis of Medical Expenditure Panel Survey (MEPS) data. COPD. 2005;2:311-318.
34. Gershon AS, Wang C, Guan J, Vasilevska-Tistovska J, Cicutoo L, To T. Identifying individuals with physician diagnosed COPD in health adminstrative databases. COPD. 2009;6:388-394.
35. Lacasse Y, Brooks D, Goldstein RS. Trends in the epidemiology of COPD in Canada, 1980-1995. Chest. 1999;116:306- 313.
36. Anthonisen NR, Dik N, Manfreda J, Roos LL. Spirometry and obstructive lung disease in Manitoba. Can Respir J. 2001;8:421-426.
37. Camp PG, Chaudhry M, Platt H, et al. The sex factor: Epidemiology and management of chronic obstructive pulmonary disease in British Columbia. Can Respir J. 2008; 15:417-422.
38. Lacasse Y, Montori VM, Lanthier C, Maltais F. The validity of diagnosing chronic obstructive pulmonary disease from a large administrative database. Can Respir J. 2005;12:251-256.